Clinical Trials

NCT Number: NCT05010200 Phase: Phase 1 Trial Summary: This proof of concept study is designed to test the safety and tolerability of PGV001-based personalized multi-peptide vaccines in combination with CDX-301 in subjects with a histo – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Ashutosh Kumar Tewari Acronym: PGV-Prostate

NCT Number: NCT05225428 Phase: Not Applicable Trial Summary: The overall study objective of this trial study is to identify and evaluate strategies to improve the accessibility of the video education with result dependent disclosure (VERDI) model, increasingly – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Dana-Farber Cancer Institute Acronym: VERDI

NCT Number: NCT05471414 Phase: Not Applicable Trial Summary: The study is comparing the effect on weight of providing home-delivered whole-food, plant-based meals versus standard, general nutritional counseling to men with prostate cancer on androgen-deprivatio – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Weill Medical College of Cornell University Acronym: WFPBD

NCT Number: NCT05754658 Phase: Trial Summary: he goal of this study is to develop a comprehensive characterization of genetic and molecular drivers of breast and prostate cancer in individuals of – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Fox Chase Cancer Center Acronym:

NCT Number: NCT05367440 Phase: Phase 1|Phase 2 Trial Summary: This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of AZD5305 when given in combination with new hormonal agents ( – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): AstraZeneca Acronym: PETRANHA

NCT Number: NCT05396872 Phase: Not Applicable Trial Summary: This project proposes to understand and improve Veterans’ decision-making in precision oncology (germline testing, somatic tumor testing, and targeted therapy) for advanced prostat – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of California, San Francisco Acronym:

NCT Number: NCT03129139 Phase: Phase 1 Trial Summary: A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™Capsules given daily for 21 days followed by 7 days off schedule – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Minneamrita Therapeutics LLC Acronym: Minnelide 101

NCT Number: NCT04552509 Phase: Not Applicable Trial Summary: The purpose of this study is to determine the effects of TrueBeam stereotactic body radiosurgery in patients with prostate cancer. The device is designed to concentrate large doses – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Linda Chan, MD Acronym:

NCT Number: NCT04848337 Phase: Phase 2 Trial Summary: Eligible patients will be treated with the combination of lenvatinib and pembrolizumab. A cycle equals 21 days and therapy will continue until radiographic progression, intolerable – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Michigan Rogel Cancer Center Acronym: PLANE-PC

NCT Number: NCT05751941 Phase: Phase 2 Trial Summary: This study is designed to test the hypothesis that using Sipuleucel-T (Provenge) in combination with new hormonal agents (NHA) (abiraterone, enzalutamide, apalutamide) for the trea – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): H. Lee Moffitt Cancer Center and Research Institute Acronym: